Cargando…
Enhanced Chondrogenic Capacity of Mesenchymal Stem Cells After TNFα Pre-treatment
Mesenchymal stem cells (MSCs) are promising cells to treat cartilage defects due to their chondrogenic differentiation potential. However, an inflammatory environment during differentiation, such as the presence of the cytokine TNFα, inhibits chondrogenesis and limits the clinical use of MSCs. On th...
Autores principales: | Voskamp, Chantal, Koevoet, Wendy J. L. M., Somoza, Rodrigo A., Caplan, Arnold I., Lefebvre, Véronique, van Osch, Gerjo J. V. M., Narcisi, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344141/ https://www.ncbi.nlm.nih.gov/pubmed/32714905 http://dx.doi.org/10.3389/fbioe.2020.00658 |
Ejemplares similares
-
Senescence during early differentiation reduced the chondrogenic differentiation capacity of mesenchymal progenitor cells
por: Voskamp, Chantal, et al.
Publicado: (2023) -
Angiogenic Potential of Tissue Engineered Cartilage From Human Mesenchymal Stem Cells Is Modulated by Indian Hedgehog and Serpin E1
por: Nossin, Yannick, et al.
Publicado: (2020) -
Hybrid Bioprinting of Chondrogenically Induced Human Mesenchymal Stem Cell Spheroids
por: De Moor, Lise, et al.
Publicado: (2020) -
Enamel Matrix Derivative has No Effect on the Chondrogenic Differentiation of Mesenchymal Stem Cells
por: Groeneveldt, Lisanne C., et al.
Publicado: (2014) -
Chondrogenic differentiation of mesenchymal stem cells through cartilage matrix-inspired surface coatings
por: Zhao, Mingyan, et al.
Publicado: (2022)